Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial

By sjmartinez • October 13, 2022

Corren J, Larson D, Altman MC, Segnitz RM, Avila PC, Greenberger PA, Baroody F, Moss MH, Nelson H, Burbank AJ, Hernandez ML, Peden D, Saini S, Tilles S, Hussain I, Whitehouse D, Qin T, Villarreal M, Sever M, Wheatley LM, Nepom GT, Sanda S; Immune Tolerance Network ITN057AD CATNIP Study Team. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: a randomized controlled trial. J Allergy Clin Immunol. 2022 Oct 9:S0091-6749(22)01333-1. doi: 10.1016/j.jaci.2022.08.029. Epub ahead of print. PMID: 36223848.

Tags: Allergy, cytokine, epithelium, Inflammation, late phase, lymphocyte, mast cell, Med Peds, Publications, rhinitis, thymic stromal lymphopoietin, tolerance, tryptase

Assessment of Service Delivery Modifications by Providers Serving Families With Developmental Disabilities During the COVID-19 Pandemic

Kwak H, Jacobs NM, Nunez DM, Fernandes P. Assessment of Service Delivery Modifications by Providers Serving Families With Developmental Disabilities During the COVID-19 Pandemic. Cureus.[...]

Integrating Antiracism and Life Course Frameworks in Research with Autistic Minority Transition-Aged Youth and Young Adults

Hotez E, Hudson S, Choi KR, Kuo AA. Integrating Antiracism and Life Course Frameworks in Research with Autistic Minority Transition-Aged Youth and Young Adults. Autism[...]

INSPIRing action to prevent diabetes (INSPIRA): Rationale and description of a pilot intervention combining peer support and food voucher incentives to increase engagement in a community health worker-led diabetes prevention program

Heisler M, Quiroga G, Valbuena F, Resnicow K, Stoll S, Griauzde DH, Hofer T, Kullgren JT. INSPIRing action to prevent diabetes (INSPIRA): Rationale and description[...]